These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7484027)

  • 21. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L; Jayarajah MJ; Toner CC; Flynn PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia.
    Caldwell JE; Heier T; Kitts JB; Lynam DP; Fahey MR; Miller RD
    Br J Anaesth; 1989 Oct; 63(4):393-9. PubMed ID: 2530998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between suxamethonium and mivacurium or atracurium.
    Kim KS; Na DJ; Chon SU
    Br J Anaesth; 1996 Nov; 77(5):612-6. PubMed ID: 8957977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of atracurium-induced neuromuscular block in paediatric patients.
    Kirkegaard-Nielsen H; Meretoja OA; Wirtavuori K
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):906-11. PubMed ID: 8848890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suxamethonium-neostigmine interaction in patients with normal or atypical cholinesterase.
    Baraka A
    Br J Anaesth; 1977 May; 49(5):479-84. PubMed ID: 861116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinesterases and subsequent duration of block of suxamethonium.
    Graham SG
    Br J Anaesth; 1997 Apr; 78(4):480-1. PubMed ID: 9135338
    [No Abstract]   [Full Text] [Related]  

  • 35. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
    Hayes A; Breslin D; Reid J; Mirakhur RK
    Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of suxamethonium given during recovery from atracurium.
    Scott RP; Norman J
    Br J Anaesth; 1988 Sep; 61(3):292-6. PubMed ID: 3179148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.